14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:MIRN
Delisted

Mirna Therapeutics Fund Signals

$1.71
+0 (+0%)
At Close: Sep 08, 2017

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -1.340 8 days ( 0 % )
Last Price $1.71 0 %
High/ Low $1.65 - $1.75 6.06%
Chg 7 Days N/A $1.71 $1.71
Chg 30 Days -1.72 % $1.74 $1.71
Chg 12 mos -32.14 % $2.52 $1.71
Trend - 3 mos 10.91 % Width: 25.87 %
Trend - 12 mos -4.69 % Width: 130.79 %
Pred. range - 3 mos $1.79 - $2.24 4.42 % - 31.02 %
Pred. range - 12 mos $1.00 - $2.31 -41.48 % - 34.88 %
Short MA avg 3 mos Buy Aug 24, 2017 - 11 days
Long MA avg 3 mos Buy Aug 24, 2017 - 11 days
Short/Long MA avg 3 mos Buy Aug 30, 2017 - 7 days
Short MA avg 12 mos Buy Aug 24, 2017 - 11 days
Long MA avg 12 mos Buy Sep 05, 2017 - 4 days
Short/Long MA avg 12 mos Buy Sep 07, 2017 - 2 days
Pivot Short Sell Sep 07, 2017 - 2 days
Bollinger Buy Jul 14, 2017 - 40 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Mirna Therapeutics

Mirna Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of microRNA-based oncology therapeutics. The company is developing mimics of naturally occurring microRNAs (miR) that are designed to restore tumor suppressor activity and aid appropriate anti-tumor immune response. Its lead product candidate is MRX34, a mimic of naturally occurring microRNA-34 encapsulated in a liposomal nanoparticle formulation which is in... MIRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT